Companies › CURX

CURANEX PHARMACEUTICALS INC (CURX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0002025942 · EDGAR filings · Updated 2026-07-21

CURANEX PHARMACEUTICALS INC (CURX) has reported institutional ownership of 1.2%, with 8 institutional managers holding positions valued at $167.6K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-21 — Employee-plan registration (S-8) filed
• 2026-06-29 — DEF 14C filed
• 2026-06-18 — PRE 14C filed
• 2026-05-14 — Current report (8-K) filed
• 2026-05-14 — Quarterly report (10-Q) filed
• 2026-05-07 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CURANEX PHARMACEUTICALS INC has 8 institutional holders and institutional ownership of 1.2%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 3 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

MATINAS BIOPHARMA HLDGS INC (MTNB) · XTL BIOPHARMACEUTICALS LTD (XTLB) · Genprex Inc (GNPX) · HCW Biologics Inc (HCWB) · SONOMA PHARMACEUTICALS INC (SNOA) · VivoSim Labs Inc (VIVS)